Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Polinsky

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Mutation Research|January 1, 1986
Alzheimer disease fibroblasts are hypersensitive to the lethal effects of a DNA-damaging chemicalD A Scudiero, R J Polinsky, R A Brumback, et al.
Science (New York, N.Y.)|February 27, 1981
Essential hypertension: central and peripheral norepinephrineC R Lake, H G Gullner, R J Polinsky, et al.
American Journal of Medical Genetics|May 1, 1993
Linkage of familial Alzheimer disease to chromosome 14 in two large early-onset pedigrees: effects of marker allele frequencies on lod scoresA Nechiporuk, P Fain, E Kort, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1991
Hippocampal lesions in dominantly inherited Alzheimer's diseaseR G Struble, R J Polinsky, J C Hedreen, et al.
Acta Neurologica Scandinavica|May 12, 1998
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's diseaseN R Cutler, R J Polinsky, J J Sramek, et al.
Mutation Research|July 1, 1989
Decreased DNA repair in familial Alzheimer's diseaseS K Jones, L E Nee, L Sweet, et al.
Neurology|August 1, 1984
Alpha-adrenergic receptors in orthostatic hypotension syndromesM S Kafka, R J Polinsky, A Williams, et al.
Basic Life Sciences|January 1, 1985
Hypersensitivity to DNA-damaging agents in abiotrophies: a new explanation for degeneration of neurons, photoreceptors, and muscle in Alzheimer, Parkinson and Huntington diseases, retinitis pigmentosa, and Duchenne muscular dystrophyJ H Robbins, R A Brumback, R J Polinsky, et al.
Advances in Biochemical Psychopharmacology|January 1, 1984
Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPGI J Kopin, P Blombery, M H Ebert, et al.
Annals of Neurology|October 1, 1989
Patterns of plasma levels of catechols in neurogenic orthostatic hypotensionD S Goldstein, R J Polinsky, M Garty, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Mutation Research|January 1, 1986
Alzheimer disease fibroblasts are hypersensitive to the lethal effects of a DNA-damaging chemicalD A Scudiero, R J Polinsky, R A Brumback, et al.
Science (New York, N.Y.)|February 27, 1981
Essential hypertension: central and peripheral norepinephrineC R Lake, H G Gullner, R J Polinsky, et al.
American Journal of Medical Genetics|May 1, 1993
Linkage of familial Alzheimer disease to chromosome 14 in two large early-onset pedigrees: effects of marker allele frequencies on lod scoresA Nechiporuk, P Fain, E Kort, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1991
Hippocampal lesions in dominantly inherited Alzheimer's diseaseR G Struble, R J Polinsky, J C Hedreen, et al.
Acta Neurologica Scandinavica|May 12, 1998
Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's diseaseN R Cutler, R J Polinsky, J J Sramek, et al.
Mutation Research|July 1, 1989
Decreased DNA repair in familial Alzheimer's diseaseS K Jones, L E Nee, L Sweet, et al.
Neurology|August 1, 1984
Alpha-adrenergic receptors in orthostatic hypotension syndromesM S Kafka, R J Polinsky, A Williams, et al.
Basic Life Sciences|January 1, 1985
Hypersensitivity to DNA-damaging agents in abiotrophies: a new explanation for degeneration of neurons, photoreceptors, and muscle in Alzheimer, Parkinson and Huntington diseases, retinitis pigmentosa, and Duchenne muscular dystrophyJ H Robbins, R A Brumback, R J Polinsky, et al.
Advances in Biochemical Psychopharmacology|January 1, 1984
Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPGI J Kopin, P Blombery, M H Ebert, et al.
Annals of Neurology|October 1, 1989
Patterns of plasma levels of catechols in neurogenic orthostatic hypotensionD S Goldstein, R J Polinsky, M Garty, et al.
Pageof 9